BioMarin Q3 Loss Narrower Than Expected, View Raised
October 24, 2014 at 15:58 PM EDT
The raised outlook reflects the continued strong performance of Vimizim and updated expectations. The market responded positively today.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.